148 related articles for article (PubMed ID: 10387543)
1. Economic outcomes of a targeted intervention program: the costs of treating allergic rhinitis patients.
Santos R; Cifaldi M; Gregory C; Seitz P
Am J Manag Care; 1999 Apr; 5(4 Suppl):S225-34. PubMed ID: 10387543
[TBL] [Abstract][Full Text] [Related]
2. Targeted intervention programs: creating a customized practice model to improve the treatment of allergic rhinitis in a managed care population.
Gregory C; Cifaldi M; Tanner LA
Am J Manag Care; 1999 Apr; 5(4):485-96. PubMed ID: 10387387
[TBL] [Abstract][Full Text] [Related]
3. The costs of nonsedating antihistamine therapy for allergic rhinitis in managed care: an updated analysis.
Liao E; Leahy M; Cummins G
Am J Manag Care; 2001 Oct; 7(15 Suppl):S459-68. PubMed ID: 11680261
[TBL] [Abstract][Full Text] [Related]
4. Economic burden of rhinitis in managed care: a retrospective claims data analysis.
Dalal AA; Stanford R; Henry H; Borah B
Ann Allergy Asthma Immunol; 2008 Jul; 101(1):23-9. PubMed ID: 18681080
[TBL] [Abstract][Full Text] [Related]
5. Optimizing quality of care and cost effectiveness in treating allergic rhinitis in a managed care setting.
Nash DB; Sullivan SD; Mackowiak J
Am J Manag Care; 2000 Jan; 6(1 Suppl):S3-15; quiz S19-20. PubMed ID: 11009751
[TBL] [Abstract][Full Text] [Related]
6. Economic burden of allergic rhinitis in Korea.
Kim SY; Yoon SJ; Jo MW; Kim EJ; Kim HJ; Oh IH
Am J Rhinol Allergy; 2010; 24(5):e110-3. PubMed ID: 21244726
[TBL] [Abstract][Full Text] [Related]
7. A descriptive analysis of the use and cost of new-generation antihistamines in the treatment of allergic rhinitis: a retrospective database analysis.
Lee J; Cummins G; Okamoto L
Am J Manag Care; 2001 May; 7(4 Suppl):S103-12. PubMed ID: 11392821
[TBL] [Abstract][Full Text] [Related]
8. [Medico-economic aspects of the management of perennial allergic rhinitis in general medicine].
Dessi P; Allaert FA; Urbinelli R; Verrière JL
Allerg Immunol (Paris); 1998 Nov; 30(9):277-83. PubMed ID: 9887986
[TBL] [Abstract][Full Text] [Related]
9. Treating allergic rhinitis: continuous versus on-demand regime? Executive summary of the Supportive Initiatives for the Global Management of Allergy (SIGMA): report from the Belgian Working Group.
Church MK; Watelet JB;
B-ENT; 2009; 5 Suppl 12():1-25. PubMed ID: 19475789
[TBL] [Abstract][Full Text] [Related]
10. Pharmacoeconomic assessment of specific immunotherapy versus current symptomatic treatment for allergic rhinitis and asthma in France.
Omnes LF; Bousquet J; Scheinmann P; Neukirch F; Jasso-Mosqueda G; Chicoye A; Champion L; Fadel R
Eur Ann Allergy Clin Immunol; 2007 May; 39(5):148-56. PubMed ID: 17626329
[TBL] [Abstract][Full Text] [Related]
11. [Allergic rhinitis--an epidemiological, economical and social problem of the XXI century].
Rutkowski R; Kosztyła-Hojna B; Rutkowska J
Pneumonol Alergol Pol; 2008; 76(5):348-52. PubMed ID: 19003765
[TBL] [Abstract][Full Text] [Related]
12. Costs associated with persistent allergic rhinitis are reduced by levocetirizine.
Bousquet J; Demarteau N; Mullol J; van den Akker-van Marle ME; Van Ganse E; Bachert C;
Allergy; 2005 Jun; 60(6):788-94. PubMed ID: 15876309
[TBL] [Abstract][Full Text] [Related]
13. Seasonal versus perennial allergic rhinitis: drug and medical resource use patterns.
Crown WH; Olufade A; Smith MW; Nathan R
Value Health; 2003; 6(4):448-56. PubMed ID: 12859586
[TBL] [Abstract][Full Text] [Related]
14. The cost of productivity losses associated with allergic rhinitis.
Crystal-Peters J; Crown WH; Goetzel RZ; Schutt DC
Am J Manag Care; 2000 Mar; 6(3):373-8. PubMed ID: 10977437
[TBL] [Abstract][Full Text] [Related]
15. Effect of a concomitant diagnosis of allergic rhinitis on asthma-related health care use by adults.
Price D; Zhang Q; Kocevar VS; Yin DD; Thomas M
Clin Exp Allergy; 2005 Mar; 35(3):282-7. PubMed ID: 15784104
[TBL] [Abstract][Full Text] [Related]
16. The burden of rhinitis in a managed care organization.
Schatz M; Zeiger RS; Chen W; Yang SJ; Corrao MA; Quinn VP
Ann Allergy Asthma Immunol; 2008 Sep; 101(3):240-7. PubMed ID: 18814446
[TBL] [Abstract][Full Text] [Related]
17. Allergic rhinitis: evidence for impact on asthma.
Thomas M
BMC Pulm Med; 2006 Nov; 6 Suppl 1(Suppl 1):S4. PubMed ID: 17140422
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and treatment of allergic rhinitis: primary care in an integrated health system setting.
Keslin MH; Jarrell CM; Gregory C
Am J Manag Care; 1999 Apr; 5(4 Suppl):S248-56; quiz S257-8. PubMed ID: 10387544
[TBL] [Abstract][Full Text] [Related]
19. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis.
Bachert C; Bousquet J; Canonica GW; Durham SR; Klimek L; Mullol J; Van Cauwenberge PB; Van Hammée G;
J Allergy Clin Immunol; 2004 Oct; 114(4):838-44. PubMed ID: 15480324
[TBL] [Abstract][Full Text] [Related]
20. The economic burden of allergic rhinitis: a critical evaluation of the literature.
Reed SD; Lee TA; McCrory DC
Pharmacoeconomics; 2004; 22(6):345-61. PubMed ID: 15099121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
